Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Reversal of general anesthesia by administration of methylphenidate, amphetamine, modafinil, amantadine, and/or caffeine

Reversal of general anesthesia by administration of methylphenidate, amphetamine, modafinil, amantadine, and/or caffeine

US Patent 11723589 · Granted Aug 15, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Dextroamphetamine and lisdexamfetamine to reverse dexmedetomidine sedation2025
Systems and methods to infer brain state during burst suppression2025
Methods and devices for providing a stimulus to a subject to induce gamma oscill2025
Methods and devices for providing a stimulus to a subject to induce gamma oscill2025
Tethered interleukin-2 to its receptor IL-2RBETA, a platform to enhance natural 2025
Methods and systems for modulating unconsciousness or anesthesia in a subject2024
Tracking nociception under anesthesia using a multimodal metric2024
Systems and methods for monitoring a subject under the influence of drugs2024
Systems and methods for predicting arousal to consciousness during general anest2023
System and method for tracking brain states during administration of anesthesia2023
System and method for automated ovarian follicular monitoring2023
Reversal of general anesthesia by administration of methylphenidate, amphetamine2023